How Agentic AI Will Reshape Life Sciences by 2028
Discover why AI-driven payers, providers, and regulators are pushing life sciences organizations to rethink commercial models, evidence strategies, and GxP validation—and what to do next.
Agentic AI is moving from pilot to production—and organizations that adapt fastest will gain a durable competitive edge across the value chain. In this complimentary Gartner® report, Predicts 2026: Agentic AI Reshapes Competitive Advantage in Life Sciences, you’ll learn how leading life sciences organizations are preparing for an AI-first future.
Gartner Key Predictions
Inside the report, Gartner predicts:
- By 2028, over 70% of healthcare payers, providers, and consumers will adopt AI, rendering traditional pharma commercial models and supporting technologies obsolete.
- By 2028, 30% of life sciences organizations will implement new software testing frameworks to validate AI-augmented solutions, optimizing key processes by 20%.
These shifts will redefine how life sciences companies engage stakeholders, generate evidence, and bring therapies to market.
Predicts 2026: Agentic AI Reshapes Competitive Advantage in Life Sciences
In this Gartner report, we believe you’ll learn how to:
- Anticipate how AI adoption by providers, payers, and patients will change engagement models, channel mix, and the role of the field force.
- Prepare regulatory submissions for AI consumption by adding semantic layers and machine-interpretable clinical rationale.
- Build pragmatic GxP validation strategies for GenAI and agentic AI, balancing innovation with compliance and risk management.
- Identify high-value agentic AI use cases and select platforms that enable monitoring, observability, and safe automation across workflows.
Complete the form to access your complimentary copy of the Gartner report.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Predicts 2026: Agentic AI Reshapes Competitive Advantage in Life Sciences, Animesh Gandhi, Reuben Harwood, Jeff Smith, Michael Shanler, 16 December 2025.
Gartner is a trademark of Gartner, Inc. and/or its affiliates.
Explore Trinity’s 2026 AI Predictions
Trinity’s experts recently hosted a webinar, “AI Predictions for 2026,” examining how AI–powered virtual assistants, dynamic HCP engagement, intelligent patient support, and accelerated clinical trials will reshape life sciences customer engagement.
Watch the on–demand webinar to see how leading organizations are putting these ideas into practice.